Clinical trials
No longer available Multiple Myeloma trials in the United States
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
9 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2007 | 1 |
| 2009 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| No longer available | 9 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Barbara Ann Karmanos Cancer Institute | 1 |
| Celgene | 1 |
| Dana-Farber Cancer Institute | 1 |
| Millennium Pharmaceuticals, Inc. | 1 |
| Novartis Pharmaceuticals | 1 |
| Pfizer | 1 |
| Sundar Jagannath | 1 |
| TeneoOne Inc. | 1 |
| University of Arkansas | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Multiple Myeloma | 9 |
| Recurrence | 3 |
| Blast Crisis | 1 |
| Burkitt Lymphoma | 1 |
| Congenital Abnormalities | 1 |
| Dendritic Cell Sarcoma, Interdigitating | 1 |
| Hodgkin Disease | 1 |
| Immunoglobulin Light-chain Amyloidosis | 1 |
| Leukemia | 1 |
| Leukemia, Erythroblastic, Acute | 1 |
Trials
Showing 1 to 9 of 9. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.